ARCHIVES

FDA Moves To Revoke Avastin’s Breast Cancer Accelerated Approval, Genentech Vows To Fight

This article is from The Cancer Letter archive.

Vol. 36 No. 46 | December 17, 2010

Download PDF Visit The Full Archive

Related Articles

In Brief: ACS Estimates 502,000 U.S. Cancer Deaths, 178,000 Avoidable With Early Diagnosis

March 17, 1989

Caplan: NEJM Should Go “The Extra Moral Mile”

January 9, 2009

Moses, Earp to lead AACI. Funding opportunities.

September 12, 2003

Adding Topotecan To Standard Treatment Doesn’t Improve Progression-Free Survival

October 29, 2010

AACI Remains Split On Guidelines; Terry Proposes 25 Percent Limit On Staff Investigator Salaries

January 30, 1981

Cancer Policy Board urges distinct care for cancer survivors.

November 11, 2005